MEDITECH(603990)2024-10-30 14:26Financial Performance - The company's operating revenue for Q3 2024 was ¥104,020,290.73, a decrease of 47.11% compared to the same period last year[2]. - The net profit attributable to shareholders for Q3 2024 was -¥90,885,620.25, indicating a significant loss[2]. - The company reported a basic earnings per share of -¥0.30 for Q3 2024, compared to -¥0.55 for the same period last year[3]. - Net profit for the first three quarters of 2024 was a loss of ¥166,251,751.36, compared to a loss of ¥88,540,155.99 in the same period of 2023[17]. - Basic and diluted earnings per share for the current period were both -¥0.55, worsening from -¥0.30 in the previous year[18]. Assets and Liabilities - The total assets at the end of the reporting period were ¥3,306,124,400.24, down 15.56% from the end of the previous year[3]. - The total equity attributable to shareholders decreased to ¥916,733,272.32, down 16.38% from the previous year[3]. - The company's cash and cash equivalents decreased to ¥186,784,138.13 from ¥478,230,565.79, a decline of approximately 60.91%[12]. - Accounts receivable increased to ¥225,291,059.43 from ¥211,492,538.71, an increase of about 6.67%[12]. - Total liabilities decreased to ¥2,385,142,373.65 from ¥2,815,714,892.79, a reduction of about 15.26%[13]. - The total current liabilities decreased to ¥1,493,443,919.20 from ¥1,858,084,190.87, a decrease of approximately 19.63%[13]. - The company reported a significant reduction in short-term borrowings from ¥505,783,200.05 to ¥380,498,641.35, a decrease of about 25%[13]. Cash Flow - The net cash flow from operating activities for the year-to-date was -¥45,585,403.83, reflecting a decline in operational efficiency[3]. - Cash inflow from operating activities totaled ¥529,915,889.03, an increase from ¥490,606,939.11 in the same period last year[19]. - Cash outflow from operating activities decreased to ¥575,501,292.86 from ¥806,193,282.19 year-over-year[19]. - The net cash flow from operating activities was -45,585,403.83, compared to -315,586,343.08 in the previous year[20]. - The net increase in cash and cash equivalents was -268,808,092.85, compared to -596,003,699.21 in the previous year[20]. - The ending balance of cash and cash equivalents was 144,121,483.02, down from 285,955,937.60 year-over-year[20]. Operational Challenges - The company experienced a decline in photovoltaic product sales and prices, contributing to the overall loss[7]. - The company plans to address the challenges in the photovoltaic sector to improve future performance[7]. Shareholder Information - The total number of common shareholders at the end of the reporting period is 29,893[9]. - The largest shareholder, Mianyang Haoxiang Holdings Co., Ltd., holds 49,220,145 shares, accounting for 16.07% of total shares[9]. Expenses and Costs - Total operating costs increased significantly to ¥579,593,276.48, up 36.8% from ¥423,715,983.61 year-over-year[15]. - Research and development expenses rose to ¥43,316,194.03, a 32.5% increase compared to ¥32,679,548.62 in the previous year[15]. - The company reported a significant increase in financial expenses, with interest expenses rising to ¥54,189,873.84 from ¥15,995,743.43 in the previous year[15]. - Other income surged to ¥90,917,149.68, compared to ¥9,683,558.91 in the same period of 2023[15].